Tags:
Filed under: Events
The Supreme Court on the 25th of June, decided to hear the Public Interest Litigation (PIL), filed by an advocate named M L Sharma, which asks for a ban on medicines manufactured by the company Ranbaxy. This news doesn't come as a surprise as the company has a history of going in for settlements under fraud cases with the US and Japan, on issues concerning falsified data and short-cut processes involving its medicines. Though the Supreme Court has rejected the PIL, asking for substantial ...